Articles
8 June 2009
Vol. 2 No. 7: New Insights in Hematology, Venice (Italy), May 14-17, 2006
https://doi.org/10.4081/hmr.v2i7.423

Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed aggressive non-Hodgkin’s lymphoma

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
180
Views
153
Downloads

Authors

P Corradini
support@pagepress.org
A Dodero
M Bregni
A Olivieri
P Valagussa
L Farina
We conducted a multicenter phase II trial for salvage treatment of relapsed lymphomas; 170 pts received allogeneic SCT from HLA identical sibling donors at 22 italian centers. RIC regimen included thiotepa, fludarabine and cyclophosphamide. GVHD prophylaxis consisted of cyclosporine A and short-course methotrexate.

Altmetrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed aggressive non-Hodgkin’s lymphoma. (2009). Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.423